Last update:

Clinical pharmacology news

Influencers promoting prescription drugs on social media pose public health risks

In today's world, attention is increasingly focused on social media and its influencers, a shift reflected in the industry's rapid growth and a global market projected to surpass $32 billion. The marketing teams of pharmaceutical ...

Common blood pressure drug can boost cancer treatment

In a new Dartmouth Cancer Center (DCC) study led by clinical researcher Tyler J. Curiel, MD, MPH, FACP, investigators found that the FDA-approved blood pressure drug telmisartan can significantly enhance the cancer-killing ...

FDA approves Icotyde for moderate-to-severe plaque psoriasis

The U.S. Food and Drug Administration has approved Johnson & Johnson's Icotyde (icotrokinra), an interleukin-23 (IL-23) receptor antagonist, for the treatment of moderate-to-severe plaque psoriasis in adults and pediatric ...

Cancer drug can treat drug-resistant herpes, too

UIC researchers have successfully repurposed an FDA-approved cancer drug, doxorubicin, to treat drug-resistant strains of herpes. Their work appears in the journal Drug Resistance Updates.

FDA approves higher-dose Wegovy to help people lose more weight

A stronger version of the popular weight loss drug Wegovy is on the way after federal regulators signed off on a higher dose. The U.S. Food and Drug Administration (FDA) approved a 7.2-milligram dose of Novo Nordisk's semaglutide, ...

Discovery might inform new approach to Huntington's disease

Treatments that target a fragment of the mutant protein that causes Huntington's disease might be more effective than treatments—now in clinical trials—that target the whole protein but leave this fragment intact, a new ...

Researchers finally report some good news on endometriosis

This year, International Women's Day coincides with Endometriosis Awareness Month. Endometriosis is a common and painful gynecological disease that impacts 14% of women and girls across the world—currently, there is no ...

Promising active substance against hepatitis E identified

Around 70,000 people die each year from infections with the hepatitis E virus. There is currently neither a vaccine nor a specific drug against this virus. This could change with the identification of bemnifosbuvir as a compound ...